Sales and Marketing

Showing 15 posts of 11526 posts found.

immatics image

immatics’ vaccine increases survival in kidney cancer

July 30, 2012 Research and Development, Sales and Marketing IMA901, Vaccine, Yervoy, immatics, phase III

immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …
Prevenar 13 image

Prevenar 13 rejected for UK vaccination programme

July 27, 2012 Sales and Marketing JCVI, Pfizer, Pneumovax, Sanofi Pasteur, prevenar 13

The UK’s joint committee on vaccination and immunisation is recommending against a switch to Pfizer’s pneumococcal vaccine Prevenar 13 from …
Roche image

Roche posts strong sales results

July 27, 2012 Sales and Marketing Pegasys, Perjeta, Roche, Zelboraf, dalcetrapib

Roche has published healthy revenue growth for the first half of 2012, but its profits have taken a hit. The …
d-heymann

Acting chair of Public Health England appointed

July 26, 2012 Sales and Marketing David Heymann, Public Health England

David Heymann has been appointed as the acting chair of Public Health England. Dr Heymann, currently chairman of the Health …
Astrazeneca image

AstraZeneca’s Fluenz chosen for wider flu immunisation

July 26, 2012 Sales and Marketing AZ, AstraZeneca, Cervarix, Gardasil, Lansley, MedImmune

The UK has chosen AstraZeneca’s Fluenz to extend the country’s flu vaccination programme. The health secretary Andrew Lansley said that …
Astrazeneca image

AstraZeneca sees big sales drop in Q2

July 26, 2012 Sales and Marketing AstraZeneca, Brennan, Brilinta, Q2, Seroquel

AstraZeneca has today reported a large drop in revenue for the second quarter. The firm has been hit by major …

The fight over ‘Obamacare’ goes on

July 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Medicaid, Obama, Obamacare, Romney, US, healthcare

The recent ruling by the US Supreme Court which upheld President Obama’s healthcare reforms could save the country around $84 …
Avastin image

Lucentis price cut ends PCT-Novartis dispute

July 26, 2012 Sales and Marketing ABPI, NHS, PCTs, Roche, SHIP Cluster, avastin

An NHS body has been persuaded to reverse its policy of recommending Avastin for wet AMD. The Southampton, Hampshire, Isle …
anne_sutton

NHS Commissioning Board appoints key directors

July 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Sutton, Lyn Simpson, NHS Commissioning, PCT

The NHS Commissioning Board Authority has announced the appointment of the two director posts in the national leadership team of …

GSK falters in Q2 as austerity measures bite

July 25, 2012 Sales and Marketing Benylsta, GSK, Q2, Seretide, Witty

GlaxoSmithKline posted a loss in its second quarter results, as pressure in mature markets continues to affect the firm. Pharmaceutical …

Europe looking to revamp clinical trial laws

July 25, 2012 Research and Development, Sales and Marketing EFPIA, EU, Europe, clinical trials

The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …
Forest labs image

FDA approves Forest’s COPD drug

July 25, 2012 Sales and Marketing COPD, FDA, Forest, Tudorza Pressair

US regulators have approved Forest Laboratories’ new chronic obstructive pulmonary disease (COPD) drug. Tudorza Pressair (aclidinium bromide) has been given …
bod_guiheen_lg

ADMA Biologics appoints Lawrence Guiheen to board of directors

July 25, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ADMA Biologics, Lawrence Guiheen

Late-stage biotech firm ADMA Biologics has announced it has appointed Lawrence Guiheen to its board of directors. Guiheen said: “Having …

Physios and podiatrists to gain new prescribing powers

July 25, 2012 Sales and Marketing Department of Health, GPs, Physios, government, prescribing

Physiotherapists and podiatrists are set to gain new prescribing powers by 2014.  Ministers are looking to amend medicines legislation so …
Xarelto image

NICE yes for Xarelto to treat blood clots

July 25, 2012 Sales and Marketing Bayer, DVT, NHS, NICE, Pradaxa, VTE, Xarelto

NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in …
The Gateway to Local Adoption Series

Latest content